Moschamine is a very potent compound that is able to inhibit COX-I by 58% and COX-II by 54%, at the concentration of 0.1 μmol L⁻1, it may suppress cAMP formation via binding to 5-HT1 receptors in the cells. Moschamine exerts antitumour effects on HeLa, MCF7 and A431 cells.

Ontuxizumab (MORAb-004) is a potent IgG1/κ monoclonal antibody targeting endomelanic acid with anti-tumor effects.

Quercetin 3-O-6'''-O-(Z)-coumaroyl-β-D-giucopyranosyl-(1→2)-α-L-rhamnosyl-7-O- β-D-glucopyranoside